Highlights ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 05/12/2025 GMT			5-day change	1st Jan Change
256.55 ^USD	+2.00%		+0.28%	+12.18%

12-04	Resmed Insider Sold Shares Worth $502,940, According to a Recent SEC Filing	MT
12-02	LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025	CI

Highlights

Ex-dividend day	11-12	FA
ResMed Insider Sold Shares Worth $2,000,773, According to a Recent SEC Filing	11-11	MT
ResMed CFO Sells Shares	11-05	MT
ResMed CFO Buys, Sells Shares	11-05	MT
Resmed Insider Sold Shares Worth $742,620, According to a Recent SEC Filing	11-04	MT
ResMed CFO Sells Shares	11-03	MT
ASX Midday Sector Update: Information Technology Stocks Rise, Healthcare Down	11-03	MT
Tranche Update on ResMed Inc.'s Equity Buyback Plan announced on February 27, 2014.	10-31	CI
ResMed Inc. Declares Quarterly Cash Dividend, Payable on December 18, 2025	10-30	CI
ResMed profit beat dampened by restructuring costs, higher expenses	10-30	RE
ResMed Posts Higher Fiscal Q1 Non-GAAP Earnings, Revenue	10-30	MT
ResMed Fiscal Q1 Non-GAAP Earnings, Revenue Rise	10-30	MT
Sleep apnea device maker Resmed's Q1 revenue edges past estimates on higher demand	10-30	RE
Earnings Flash (RMD) ResMed Inc. Reports Q1 Revenue $1.34B, vs. FactSet Est of $1.33B	10-30	MT
Earnings Flash (RMD) ResMed Inc. Posts Q1 Adjusted EPS $2.55 per Share, vs. FactSet Est of $2.52	10-30	MT
ResMed Inc. Reports Earnings Results for the First Quarter Ended September 30, 2025	10-30	CI
Samsung Electronics Co., Ltd. completed the acquisition of Xealth Inc.	10-16	CI
ResMed to report first quarter fiscal 2026 earnings on October 30, 2025	10-09	RE
ResMed Insider Sold Shares Worth $2,265,332, According to a Recent SEC Filing	10-09	MT
Resmed Insider Sold Shares Worth $823,080, According to a Recent SEC Filing	10-03	MT
ResMed Chief Legal Officer Sells Shares	10-02	MT
ResMed CEO Sells $2.2 Million in Shares	09-08	MT
ResMed Starts Clinical Insights Initiative to Understand Sleep Health	09-04	MT
ResMed CFO Sells Shares	09-02	MT
Ex-dividend day	08-13	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ResMed's innovation-driven success and prospects

October 31, 2025 at 08:55 am